« Back to Record
Di Leo, A., Desmedt, C., Bartlett, J. M. S., Piette, F., Ejlertsen, B., Pritchard, K., Larsimont, D., Poole, C., Isola, J., Earl, H., Mouridsen, H., O'Malley, F. P., Cardoso, F., Tanner, M., Munro, A., Twelves, C. J., Sotiriou, C., Shepherd, L., Cameron, D. A., Piccart-Gebhart, M., Buyse, M., & HER2/TOP2A Meta-analysis Study Group, (2011). HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data. Lancet oncology, 12(12), 1134-1142. doi:10.1016/S1470-2045(11)70231-5
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/113274



